© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Levofloxacin Hydrate belongs to the class of fluoroquinolone antibiotics, widely known for treating serious bacterial infections. As a chemical material, its scientific name is levofloxacin, and in its hydrate form, it absorbs water molecules, which influences both storage and handling. Levofloxacin Hydrate does not appear the same everywhere. Sometimes it comes as a white or pale yellowish crystalline powder, other times as flakes, rarely as pearls or in any sort of granulated form. A glance under good laboratory lighting shows its crystalline texture, different from the fine powders of other antimicrobials. This compound reflects a practical point for both those handling it and those studying its application in real-world pharmaceutical projects.
The chemical structure of levofloxacin hydrate stands out with the molecular formula C18H20FN3O4·H2O. This structural formation shows one water molecule bound to each levofloxacin molecule, making it distinctive compared to anhydrous variants. Its molar mass clocks in at approximately 378.38 g/mol, including the hydrate. The HS Code for levofloxacin hydrate, usually referenced for import and export, falls under 2941.90, which corresponds to antibiotics that aren’t put up in measured doses. This code matters for customs, taxes, and regulatory checks in global trading, especially between major pharmaceutical hubs and smaller manufacturing facilities.
Levofloxacin Hydrate typically registers a density of around 1.51 g/cm³ at room temperature. Its melting point ranges from about 220°C to 225°C—a mark that comes into play during synthesis and quality testing. The substance does not dissolve easily in water but shows moderate solubility in alkaline solutions, which has practical consequences for drug formulation work. Few things slow down production lines more than a compound that clumps in solution; levofloxacin hydrate, when treated with respect for its solubility limits, behaves reliably. The form—whether as a solid, powder, or flakes—can influence the ease with which a lab tech handles it, but across its physical forms, it maintains true to its core antibiotic properties.
Levofloxacin Hydrate’s properties demonstrate its value as an active pharmaceutical ingredient. The molecule’s asymmetric fluorine atom explains its chiral activity, contributing to its potency against a broad range of pathogens. Its pale yellow tint, though not always present, results from water retention and purity differences during synthesis. Suppliers sometimes prefer to market this material as a white powder for uniformity, but the key lies in batch-to-batch consistency, not just appearance. Packing this substance for transportation requires airtight containers and attention to humidity, as hydration levels shift with environmental exposure, affecting the product’s stability and shelf-life. A liter of levofloxacin solution does not simply ‘fit’ with hydrate addition; careful calculations keep content accurate, and trained personnel work to avoid cross-contamination or loss of potency.
Production of levofloxacin hydrate draws from a tightly controlled supply chain, usually beginning with fermentation products that serve as raw materials for fluoroquinolone synthesis. Any impurity in precursors can compromise the final material, impacting both chemical purity and pharmacological effectiveness. Routine quality checks entail strict verification by UV or HPLC (high-performance liquid chromatography), where both the hydrate and its impurities come into play. Pharmaceutical manufacturers keep detailed logs of batch purity, molecular characteristics, and appearance. Materials need to stay within specs to avoid downstream regulatory problems. Importers and exporters know to match the HS Code precisely, as mismatches often trigger delays, confiscations, or penalties.
Levofloxacin Hydrate warrants careful handling, given its potential to cause harm when misused. This material, like many chemicals, poses health risks if inhaled, ingested, or allowed to contact skin or eyes without protection. Laboratories keep it under controlled ventilation, using gloves, goggles, and lab coats to minimize exposure. Pharmacies that compound with levofloxacin hydrate follow clear protocols, mindful of its hazardous characteristics. MSDS (Material Safety Data Sheets) warn that this chemical may trigger allergic skin reactions, irritation of mucous membranes, and systemic toxicity if mishandled. Safe storage avoids excessive heat, moisture, and direct sunlight, guarding property and personnel.
From experience, reliable supply and safe use of levofloxacin hydrate call for transparent collaboration between suppliers, regulators, shippers, and end-users. Supply interruptions raise real-world concerns in hospitals where antibiotic resistance already challenges effective care. Pharmaceutical companies can invest in robust sourcing and redundancy, minimizing risk in case a supplier experiences recalls or logistical hiccups. Regulators should inspect not just paperwork but also onsite quality control processes to catch faults at the source. For anyone working with levofloxacin hydrate, thorough training and strict adherence to safety protocols remain non-negotiable. A well-managed chain of custody from synthesis to end-use reduces accidents and ensures the proper, effective application of this crucial antibacterial raw material.
